pt141 bremelanotide PT-141 - Research Peptide PT-141 (Bremelanotide) - Polar Peptides

The study reports that CuATSM reduces the area of murine cerebral infarction and oxidative stress and exerts antioxidant and neuroprotective effects in acute IS in a transient MCAO (tMCAO) model (Shi et al., 2021)

By burning the fatty acids, mitochondria generate energy for the body

Non-peptide GHS, like MK 677, are synthetic compounds that achieve the same results through different mechanisms according to research

Bezafibrate As a well-known pan-PPAR agonist, bezafibrate exhibits comprehensive therapeutic effects in lipid lowering and the management of non-alcoholic fatty liver disease (NAFLD) [122, 123]

Inhibition of morphine tolerance by spinal melanocortin receptor blockade

Uncontrolled use of substances from the AAS group for non-medical purposes is associated with a high risk of adverse effects on the liver and the reproductive, musculoskeletal, cardiovascular, and central nervous systems